chr12-53253667-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000329548.5(MFSD5):c.832G>A(p.Gly278Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000457 in 1,613,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00049 ( 0 hom. )
Consequence
MFSD5
ENST00000329548.5 missense
ENST00000329548.5 missense
Scores
10
9
Clinical Significance
Conservation
PhyloP100: 4.08
Genes affected
MFSD5 (HGNC:28156): (major facilitator superfamily domain containing 5) Predicted to enable molybdate ion transmembrane transporter activity. Predicted to be involved in molybdate ion transport. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.29717556).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MFSD5 | NM_032889.5 | c.832G>A | p.Gly278Arg | missense_variant | 2/2 | ENST00000329548.5 | NP_116278.3 | |
MFSD5 | NM_001170790.2 | c.1153G>A | p.Gly385Arg | missense_variant | 2/2 | NP_001164261.1 | ||
MFSD5 | XM_005269197.2 | c.1153G>A | p.Gly385Arg | missense_variant | 3/3 | XP_005269254.1 | ||
MFSD5 | XM_005269198.5 | c.832G>A | p.Gly278Arg | missense_variant | 2/2 | XP_005269255.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MFSD5 | ENST00000329548.5 | c.832G>A | p.Gly278Arg | missense_variant | 2/2 | 1 | NM_032889.5 | ENSP00000332624.5 | ||
MFSD5 | ENST00000534842.1 | c.1153G>A | p.Gly385Arg | missense_variant | 2/2 | 2 | ENSP00000442688.1 | |||
MFSD5 | ENST00000551660.2 | c.1153G>A | p.Gly385Arg | missense_variant | 2/2 | 2 | ENSP00000449354.2 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152184Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
27
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000211 AC: 53AN: 251306Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135860
GnomAD3 exomes
AF:
AC:
53
AN:
251306
Hom.:
AF XY:
AC XY:
21
AN XY:
135860
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000486 AC: 711AN: 1461684Hom.: 0 Cov.: 33 AF XY: 0.000455 AC XY: 331AN XY: 727168
GnomAD4 exome
AF:
AC:
711
AN:
1461684
Hom.:
Cov.:
33
AF XY:
AC XY:
331
AN XY:
727168
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000177 AC: 27AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74348
GnomAD4 genome
AF:
AC:
27
AN:
152184
Hom.:
Cov.:
32
AF XY:
AC XY:
12
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
19
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.1153G>A (p.G385R) alteration is located in exon 2 (coding exon 2) of the MFSD5 gene. This alteration results from a G to A substitution at nucleotide position 1153, causing the glycine (G) at amino acid position 385 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;.;M
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Benign
T;T;T
Polyphen
0.99
.;.;D
Vest4
MutPred
0.54
.;.;Gain of solvent accessibility (P = 6e-04);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at